New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
20.39
0.07
−0.34%
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Revenue to profit Fiscal 2025, year to Dec 31, 2025
Of every $100 of revenue, $20.08 was left as profit. What is an income statement?
| Revenue | 774.6 | 100.0% |
|---|---|---|
| Cost of revenue | 0.0 | 0.0% |
| Gross profit | 774.6 | 100.0% |
| Selling, general & admin | −53.7 | −6.9% |
| Other operating costs | −464.4 | −59.9% |
| Operating income | 256.5 | 33.1% |
| Other income, net | −103.1 | −13.3% |
| Income tax | −1.8 | −0.2% |
| Other items | +3.9 | 0.5% |
| Net income | 155.5 | 20.1% |
Net margin (right axis)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $261M | $408M | $623M | $662M | $599M | $570M | $625M | $648M | $703M | $775M |
| Operating income | $132M | $195M | $305M | $218M | $252M | $201M | $141M | $207M | $239M | $257M |
| Net income | $70M | $158M | $279M | $69M | $138M | −$113M | −$78M | $14M | $127M | $156M |
| Net margin (right axis) | 26.9% | 38.8% | 44.8% | 10.4% | 23.1% | −19.9% | −12.4% | 2.1% | 18.0% | 20.1% |
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
260.53 | 408.28 | 623.41 | 661.74 | 598.57 | 569.55 | 624.81 | 647.51 | 703.24 | 774.63 |
Revenue Growth |
9.07% | 56.71% | 52.69% | 6.15% | (9.55%) | (4.85%) | 9.70% | 3.63% | 8.61% | 10.15% |
Gross Profit |
260.53 | 408.28 | 623.41 | 661.74 | 598.57 | 569.55 | 624.81 | 647.51 | 703.24 | 774.63 |
SG&A Expenses |
17.67 | 32.40 | 37.09 | 30.89 | 32.76 | 34.67 | 39.57 | 47.47 | 50.07 | 53.71 |
Operating Income |
132.13 | 195.44 | 304.90 | 217.77 | 251.67 | 201.25 | 140.66 | 207.19 | 238.56 | 256.55 |
Non-operating Income/Expense |
(60.87) | (36.43) | (17.34) | (138.56) | (95.94) | (120.58) | (118.99) | (188.53) | (110.44) | (103.13) |
Non-operating Interest Expenses |
64.87 | 88.44 | 147.11 | 126.61 | 100.42 | 98.63 | 105.47 | 112.96 | 115.27 | 112.49 |
Investment Gain/Loss (Other) |
— | — | (5.43) | (6.80) | (16.60) | (192.08) | (98.03) | (2.90) | (0.40) | 3.93 |
| 71.25 | 159.02 | 287.56 | 79.22 | 155.73 | 80.67 | 21.67 | 18.66 | 128.11 | 153.42 | |
Income Tax Provision |
1.05 | 0.65 | 3.01 | 3.40 | 0.71 | 1.85 | 1.24 | 2.00 | 1.01 | 1.84 |
Income after Tax |
70.21 | 158.37 | 284.55 | 75.81 | 155.02 | 78.83 | 20.43 | 16.65 | 127.11 | 151.58 |
Dividends (Preferred) |
10.24 | 10.24 | 9.77 | 0.00 | 0.00 | — | — | — | — | — |
Non-Controlling Interest |
(0.07) | (0.02) | 0.03 | 0.02 | — | — | — | — | — | (0.10) |
Net Income Common |
60.03 | 148.14 | 269.31 | 69.00 | 138.42 | (113.26) | (77.60) | 13.76 | 126.71 | 155.61 |
EPS (Basic) |
0.92 | 1.40 | 1.51 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
EPS (Diluted) |
0.92 | 1.40 | 1.51 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
Shares (Basic, Weighted) |
65.28 | 105.62 | 178.31 | 187.17 | 206.22 | 219.07 | 230.95 | 231.20 | 233.50 | 241.31 |
Shares (Diluted, Weighted) |
65.52 | 105.84 | 178.72 | 188.13 | 207.25 | 219.07 | 230.95 | 232.79 | 236.05 | 244.50 |
Gross Margin |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
EBIT Margin |
50.72% | 47.87% | 48.91% | 32.91% | 42.04% | 35.34% | 22.51% | 32.00% | 33.92% | 33.12% |
EBT margin |
27.35% | 38.95% | 46.13% | 11.97% | 26.02% | 14.16% | 3.47% | 2.88% | 18.22% | 19.81% |
Net Profit Margin |
23.04% | 36.28% | 43.20% | 10.43% | 23.12% | (19.89%) | (12.42%) | 2.12% | 18.02% | 20.09% |
Free Cash Flow Margin |
45.81% | (34.49%) | 72.82% | 94.44% | 38.64% | 55.31% | 41.03% | 59.43% | 30.63% | (7.38%) |
EBITDA |
200.60 | 309.33 | 496.28 | 399.32 | 428.40 | 380.24 | 328.44 | 390.27 | 408.18 | 443.54 |
EBIT |
132.13 | 195.44 | 304.90 | 217.77 | 251.67 | 201.25 | 140.66 | 207.19 | 238.56 | 256.55 |
Income from Continuous Operations |
70.21 | 158.37 | 279.12 | 69.02 | 138.42 | (113.26) | (77.60) | 13.76 | 126.71 | 155.51 |
Consolidated Net Income/Loss |
70.21 | 158.37 | 279.12 | 69.02 | 138.42 | (113.26) | (77.60) | 13.76 | 126.71 | 155.51 |
EPS (Basic, from Continuous Ops) |
1.08 | 1.50 | 1.57 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
EPS (Basic, Consolidated) |
1.08 | 1.50 | 1.57 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
EPS (Diluted, from Cont. Ops) |
1.07 | 1.50 | 1.56 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
Shares (Diluted, Average) |
65.52 | 105.84 | 178.72 | 188.13 | 207.25 | 219.07 | 230.95 | 232.79 | 236.05 | 244.50 |
EPS (Diluted, Consolidated) |
1.07 | 1.50 | 1.56 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
EBITDA Margin |
77.00% | 75.76% | 79.61% | 60.34% | 71.57% | 66.76% | 52.57% | 60.27% | 58.04% | 57.26% |
Operating Cash Flow Margin |
67.53% | 33.26% | 57.84% | 56.29% | 59.28% | 62.57% | 50.53% | 46.42% | 44.16% | 45.00% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026